Analysts at StockNews.com started coverage on shares of Global Indemnity Group (NASDAQ:GBLI – Get Free Report) in a report released on Tuesday. The brokerage set a “buy” rating on the insurance provider’s stock.
Global Indemnity Group Trading Down 1.5 %
NASDAQ:GBLI opened at $30.63 on Tuesday. Global Indemnity Group has a 12 month low of $26.50 and a 12 month high of $37.00. The stock has a market capitalization of $416.69 million, a price-to-earnings ratio of 12.35 and a beta of 0.45. The firm has a fifty day simple moving average of $31.39 and a two-hundred day simple moving average of $30.66.
Global Indemnity Group (NASDAQ:GBLI – Get Free Report) last issued its earnings results on Wednesday, May 8th. The insurance provider reported $0.77 EPS for the quarter, beating the consensus estimate of $0.60 by $0.17. Global Indemnity Group had a return on equity of 5.40% and a net margin of 6.98%. The company had revenue of $112.29 million during the quarter, compared to the consensus estimate of $90.00 million. Equities analysts predict that Global Indemnity Group will post 2.55 earnings per share for the current fiscal year.
Institutional Trading of Global Indemnity Group
About Global Indemnity Group
Global Indemnity Group, LLC, through its subsidiaries, provides specialty property and casualty insurance, and reinsurance products worldwide. It operates in two segments, Penn-America and Non-Core Operations. The company distributes property and general liability products for small commercial businesses through a network of wholesale general agents; and property and general liability niche products through program administrators with specific binding authority.
Further Reading
- Five stocks we like better than Global Indemnity Group
- How to Most Effectively Use the MarketBeat Earnings Screener
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- 10 Best Airline Stocks to Buy
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Business Services Stocks Investing
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Global Indemnity Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Indemnity Group and related companies with MarketBeat.com's FREE daily email newsletter.